BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Jiangbo Liu, Qingyong Ma, Min Zhang, Xinshuai Wang, Dong Zhang, Wei Li, Fengfei Wang, Erxi Wu. Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: Evidence from a systematic review and meta-analysisEuropean Journal of Cancer 2012; 48(15): 2328 doi: 10.1016/j.ejca.2012.03.001
2
Mehdi Pouraminaei, Mohammad Reza Mirzaiey, Alireza Khoshdel, Mohammad Reza Hajizadeh, Mehdi Mahmoodi, Mohammad Ali Fahmidehkar. The effect of Cressa Cretica hydroalcoholic extract on apoptosis and the expression of Bcl2, Bax and P53 genes in hepatoma cell line HepG2Gene Reports 2020; 20: 100692 doi: 10.1016/j.genrep.2020.100692
3
Sanjay Kakar. Molecular Pathology of Liver DiseasesMolecular Pathology Library 2011; 5: 849 doi: 10.1007/978-1-4419-7107-4_57
4
Laetitia Fartoux, Thomas Decaens. Contribution of biomarkers and imaging in the management of hepatocellular carcinomaClinics and Research in Hepatology and Gastroenterology 2011; 35: S21 doi: 10.1016/S2210-7401(11)70004-3
5
Ya-nan Ji, Qin Wang, Jun Xue. TP53 immunohistochemical expression is associated with the poor outcome for hepatocellular carcinoma: evidence from a meta-analysisTumor Biology 2014; 35(2): 1653 doi: 10.1007/s13277-013-1228-7
6
Wesam A. Nasif, Mohammed H. Mukhtar, Hoda M. El-Emshaty, Talaat A. AL-Bukhari. Evaluation of circulating TP53 antigen in the sera of gastric cancer patients: As a tumor markerBiomarkers and Genomic Medicine 2013; 5(4): 175 doi: 10.1016/j.bgm.2013.10.001
7
Xing-Hua Huang, Lu-Hong Sun, Dong-Dong Lu, Yan Sun, Li-Jie Ma, Xi-Ran Zhang, Jian Huang, Long Yu. Codon 249 mutation in exon 7 of <italic>p53</italic> gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, ChinaWorld Journal of Gastroenterology 2003; 9(4): 692-695 doi: 10.3748/wjg.v9.i4.692
8
Mulazim Hussain Bukhari, Shahida Niazi, Muhammad Anwar, Naseer Ahmed Chaudhry, Samina Naeem. Prognostic Significance of New Immunohistochemistry Scoring of p53 Protein Expression in Cutaneous Squamous Cell Carcinoma of MiceAnnals of the New York Academy of Sciences 2008; 1138(1): 1 doi: 10.1196/annals.1414.001
9
Christopher D. Mann, Christopher P. Neal, Giuseppe Garcea, Margaret M. Manson, Ashley R. Dennison, David P. Berry. Prognostic molecular markers in hepatocellular carcinoma: A systematic reviewEuropean Journal of Cancer 2007; 43(6): 979 doi: 10.1016/j.ejca.2007.01.004
10
Ken Yamazaki, Yohei Masugi, Michiie Sakamoto. Molecular Pathogenesis of Hepatocellular Carcinoma: Altering Transforming Growth Factor-β Signaling in HepatocarcinogenesisDigestive Diseases 2011; 29(3): 284 doi: 10.1159/000327560
11
Neeta K. Venepalli, Laura Goff. Targeting the HGF-cMET Axis in Hepatocellular CarcinomaInternational Journal of Hepatology 2013; 2013: 1 doi: 10.1155/2013/341636
12
Li-Juan Shen, Hua-Xian Zhang, Zong-Ji Zhang, Jin-Yun Li, Ming-Qin Chen, Wei-Bo Yang, Run Huang. Detection of HBV, PCNA and GST-&pi; in hepatocellular carcinoma and chronic liver diseasesWorld Journal of Gastroenterology 2003; 9(3): 459-462 doi: 10.3748/wjg.v9.i3.459
13
Xin-Juan Kong, Yu-Hu Song, Ju-Sheng Lin, Huan-Jun Huang, Nan-Xia Wang, Nan-Zhi Liu, Bin Li, You-Xin Jin. Maxizyme-mediated specific inhibition on mutant-type p53 <italic>in vitro</italic>World Journal of Gastroenterology 2003; 9(7): 1571-1575 doi: 10.3748/wjg.v9.i7.1571
14
Perumal Vivekanandan, Om V Singh. High-dimensional biology to comprehend hepatocellular carcinomaExpert Review of Proteomics 2008; 5(1): 45 doi: 10.1586/14789450.5.1.45
15
Toar J.M. Lalisang, Yefta Moenadjat, Nurjati C. Siregar, Marini Stephanie. Overexpression of p53 in extra large (more than 10 cm) hepatocellular carcinomaMedical Journal of Indonesia 2018; 27(2) doi: 10.13181/mji.v27i2.1980
16
Reza Ghasemi, Seyed H. Ghaffari, Majid Momeny, Saeed Pirouzpanah, Mehdi Yousefi, Mohsen Malehmir, Kamran Alimoghaddam, Ardeshir Ghavamzadeh. Multitargeting and Antimetastatic Potentials of Silibinin in Human HepG-2 and PLC/PRF/5 Hepatoma CellsNutrition and Cancer 2013; 65(4): 590 doi: 10.1080/01635581.2013.770043
17
Chaar Ines, Ounissi Donia, Boughriba Rahma, Azza Ben Ammar, Amara Sameh, Taher Khalfallah, Ben hmida Abdelmajid, Mzabi Sabeh, Bouraoui Saadia. Implication of K-ras and p53 in colorectal cancer carcinogenesis in Tunisian population cohortTumor Biology 2014; 35(7): 7163 doi: 10.1007/s13277-014-1874-4
18
C. Verhoef, H. van Dekken, L.J. Hofland, P.E. Zondervan, J.H.W. de Wilt, R. van Marion, R.A. de Man, J.N.M. IJzermans, C.H.J. van Eijck. Somatostatin Receptor in Human Hepatocellular Carcinomas: Biological, Patient and Tumor CharacteristicsDigestive Surgery 2008; 25(1): 21 doi: 10.1159/000117819
19
Li-Wu Lin, Xue-Ying Lin, Yi-Mi He, Shang-Da Gao, Xiao-Dong Lin. Biological characteristics of HCC by ultrasound-guided aspiration biopsy and its clinical applicationWorld Journal of Gastroenterology 2003; 9(5): 941-945 doi: 10.3748/wjg.v9.i5.941
20
Regina Cheuk-Lam Lo, Irene Oi-Lin Ng. Hepatocellular tumors: Immunohistochemical analyses for classification and prognosticationChinese Journal of Cancer Research 2011; 23(4): 245 doi: 10.1007/s11670-011-0245-6
21
Lun-Xiu Qin, Zhao-You Tang. The prognostic molecular markers in hepatocellular carcinomaWorld Journal of Gastroenterology 2002; 8(3): 385-392 doi: 10.3748/wjg.v8.i3.385
22
Zhao-Chong Zeng, Guo-Liang Jiang, Guo-Min Wang, Zhao-You Tang, Walter J. Curran, George Iliakis. DNA-PKcs subunits in radiosensitization by hyperthermia on hepatocellular carcinoma hepG2 cell lineWorld Journal of Gastroenterology 2002; 8(5): 797-803 doi: 10.3748/wjg.v8.i5.797
23
Jian-Zhen Lin, Jun-Yu Long, An-Qiang Wang, Ying Zheng, Hai-Tao Zhao. Precision medicine: In need of guidance and surveillanceWorld Journal of Gastroenterology 2017; 23(28): 5045-5050 doi: 10.3748/wjg.v23.i28.5045
24
Rageshree Ramachandran, Sanjay Kakar. Fibrolamellar hepatocellular carcinomaDiagnostic Histopathology 2010; 16(8): 388 doi: 10.1016/j.mpdhp.2010.06.005
25
Laura Gramantieri, Davide Trerè, Pasquale Chieco, Michela Lacchini, Catia Giovannini, Fabio Piscaglia, Antonino Cavallari, Luigi Bolondi. In human hepatocellular carcinoma in cirrhosis proliferating cell nuclear antigen (PCNA) is involved in cell proliferation and cooperates with P21 in DNA repairJournal of Hepatology 2003; 39(6): 997 doi: 10.1016/S0168-8278(03)00458-6
26
Michael Torbenson, Rajesh Kannangai, Susan Abraham, Fikret Sahin, Michael Choti, Jianzhou Wang. Concurrent Evaluation of p53, β-Catenin, and α-Fetoprotein Expression in Human Hepatocellular CarcinomaAmerican Journal of Clinical Pathology 2004; 122(3): 377 doi: 10.1309/YH0H3FKYM4RMU1JF
27
Richard A. Burkhart, Sean M. Ronnekleiv-Kelly, Timothy M. Pawlik. Personalized therapy in hepatocellular carcinoma: Molecular markers of prognosis and therapeutic responseSurgical Oncology 2017; 26(2): 138 doi: 10.1016/j.suronc.2017.01.009
28
Ashish Singhal, Muralidharan Jayaraman, Danny N. Dhanasekaran, Vivek Kohli. Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrenceCritical Reviews in Oncology/Hematology 2012; 82(2): 116 doi: 10.1016/j.critrevonc.2011.05.005
29
Kenji Yorita, Akinobu Ohno, Hiroaki Kataoka. Emerging histopathological prognostic biomarkers in hepatocellular carcinomasPersonalized Medicine Universe 2014; 3: 15 doi: 10.1016/j.pmu.2014.03.006
30
Shao-Shan Wang, Ti Zhang, Xi-Lu Wang, Li Hong, Qing-Hui Qi. Effect of arsenic trioxide on rat hepatocarcinoma and its renal cytotoxicityWorld Journal of Gastroenterology 2003; 9(5): 930-935 doi: 10.3748/wjg.v9.i5.930
31
Mulazim H. Bukhari, Shahida Niazi, Muhammad Eyyaz Khaleel, M. Anwar Sharif, Rubina Ghani, Muhammad T. Mehmood, Muhammad Tahseen, Naseer A. Chaudhry, Mumtaz Hasan. Elevated frequency of p53 genetic mutations and AgNOR values in squamous cell carcinomaJournal of Cutaneous Pathology 2009; 36(2): 220 doi: 10.1111/j.1600-0560.2008.01006.x
32
Laura Gramantieri, Pasquale Chieco, Catia Giovannini, Michela Lacchini, Davide Treré, Gian Luca Grazi, Annamaria Venturi, Luigi Bolondi. GADD45-α expression in cirrhosis and hepatocellular carcinoma: relationship with DNA repair and proliferationHuman Pathology 2005; 36(11): 1154 doi: 10.1016/j.humpath.2005.07.017
33
Zhao-Shan Niu, Bo-Kian Li, Mei Wang. Expression of p53 and C-myc genes and its clinical relevance in the hepatocellular carcinomatous and pericarcinomatous tissuesWorld Journal of Gastroenterology 2002; 8(5): 822-826 doi: 10.3748/wjg.v8.i5.822